Q4 EPS Estimates for Henry Schein Decreased by William Blair

Henry Schein, Inc. (NASDAQ:HSIC) – Stock analysts at William Blair dropped their Q4 2024 earnings per share (EPS) estimates for shares of Henry Schein in a research note issued on Tuesday, November 5th. William Blair analyst B. Vazquez now expects that the company will post earnings per share of $1.23 for the quarter, down from their previous forecast of $1.25. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. William Blair also issued estimates for Henry Schein’s Q1 2025 earnings at $1.16 EPS, Q4 2025 earnings at $1.36 EPS, Q1 2026 earnings at $1.27 EPS, Q2 2026 earnings at $1.42 EPS and Q3 2026 earnings at $1.42 EPS.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. Henry Schein’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.32 EPS.

Several other equities research analysts have also issued reports on HSIC. Barrington Research reiterated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research note on Wednesday. JPMorgan Chase & Co. dropped their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Robert W. Baird decreased their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Evercore ISI boosted their price target on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Finally, UBS Group cut their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $77.50.

Henry Schein Price Performance

NASDAQ HSIC opened at $69.43 on Thursday. The firm’s 50 day moving average is $70.56 and its 200-day moving average is $69.78. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $8.80 billion, a PE ratio of 25.71, a price-to-earnings-growth ratio of 2.08 and a beta of 0.87. Henry Schein has a 12-month low of $62.12 and a 12-month high of $82.63.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.14% of the company’s stock.

Hedge Funds Weigh In On Henry Schein

Several institutional investors and hedge funds have recently made changes to their positions in the company. Swedbank AB acquired a new stake in Henry Schein during the 1st quarter worth approximately $215,998,000. ING Groep NV acquired a new stake in shares of Henry Schein during the third quarter worth $63,226,000. Thompson Siegel & Walmsley LLC bought a new stake in shares of Henry Schein in the second quarter valued at about $46,683,000. SG Americas Securities LLC grew its stake in shares of Henry Schein by 1,622.3% in the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company’s stock valued at $33,449,000 after acquiring an additional 432,187 shares in the last quarter. Finally, Nuance Investments LLC increased its holdings in shares of Henry Schein by 28.5% during the first quarter. Nuance Investments LLC now owns 1,755,190 shares of the company’s stock worth $132,552,000 after purchasing an additional 388,843 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.